Creating a WRAPped membrane protein is a multi-step process. Researchers first design the WRAP to match the dimensions of the membrane protein’s hydrophobic region, then adjust it to conform to the protein’s specific shape and surface chemistry. Next, they generate a gene encoding the WRAP and fuse it to the membrane protein gene. Finally, the engineered hybrid gene is expressed in bacteria and the resulting protein is purified to yield the desired soluble WRAPped membrane protein.
Using this process, the researchers successfully created WRAPped versions of various well-characterized proteins, including E. coli outer membrane proteins, E. coli protease GlpG, and human chemokine receptor CXCR4. The WRAPped proteins were water soluble and stable. They retained the structural and functional characteristics of the native forms, including epitope specificity, ligand binding capacity, and enzymatic activity.
The team then created a more complicated WRAP, for an eight-subunit protein complex called Mycobacterium smegmatis porin A (MspA). In its native role, MspA forms a pore in the cell membrane that facilitates transport of nutrients and other small molecule in and out of the cell. The complex has also been adapted for long read DNA sequencing in biotechnology. The researchers used cryo-electron microscopy to determine a high-resolution structure of the full WRAPped protein complex. The structure was consistent with previously reported native MspA structures, maintaining both large-scale subunit configuration and small-scale individual fold architecture. This success demonstrates that WRAPs can be applied to both simple and composite proteins, and that WRAPped protein structures accurately reflect the protein’s native form.
The researchers also generated WRAPs for three Treponema pallidum outer membrane proteins. These proteins sit within the membrane of the bacterium that causes syphilis and may be ideal targets for drug and vaccine development. No one has yet been able to detail their structures. Now that the proteins are soluble with WRAPs, gathering this essential structural and antigenic information may be possible.
Moving forward, the team hopes to apply the WRAP technology to advance medicine. Pooja Bandawane, a PhD candidate in the Baker lab, indicated, “We are interested in using WRAPped antigens, like the ones we made for Treponema pallidum, to help isolate monoclonal antibodies and support vaccine development against syphilis. More broadly, we want to extend this approach to other important drug targets.”
The applications of this new technology are expansive, including structural and biochemical characterization of membrane proteins, vaccine design, drug discovery, biotechnological advancement. How far can we go with this nifty new tool?